Patent · US Active

SGK1 inhibitors for the prophylaxis and/or therapy of viral diseases and/or carcinomas

US8546613B2 · kind B2 · utility

1Cited by

1References

6Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Thomas Fuchss · Bensheim, DE
Rolf Gericke · Seeheim-Jugenheim, DE
Norbert Beier · Reinheim, DE
Florian Lang · Gilching, DE
Phillipp Lang · Lörrach, DE
Karl Lang · Essen, DE

Key dates

Filing date	Feb 17, 2009
Grant date	Oct 1, 2013
Priority date	—
Expiry date	Feb 17, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a compound of formulas I, Ia, Ib and II,wherein R1 to R11 are herein defined.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.